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Abstract
Background: Obesity is a major public health problem in both developed and developing countries alike and
leads to a series of changes in respiratory physiology. There is a strong correlation between obesity and
cardiopulmonary sleep disorders. Weight loss among such patients leads to a reduction in these alterations in
respiratory physiology, but clinical treatment is not effective for a long period of time. Thus, bariatric surgery is a
viable option.
Methods/Design: The present study involves patients with morbid obesity (BMI of 40 kg/m
2 or 35 kg/m
2 to 39.9
kg/m
2 with comorbidities), candidates for bariatric surgery, screened at the Santa Casa de Misericórdia Hospital in
the city of Sao Paulo (Brazil). The inclusion criteria are grade III morbid obesity, an indication for bariatric surgery,
agreement to participate in the study and a signed term of informed consent. The exclusion criteria are BMI above
55 kg/m
2, clinically significant or unstable mental health concerns, an unrealistic postoperative target weight and/
or unrealistic expectations of surgical treatment. Bariatric surgery candidates who meet the inclusion criteria will be
referred to Santa Casa de Misericórdia Hospital and will be reviewed again 30, 90 and 360 days following surgery.
Data collection will involve patient records, personal data collection, objective assessment of HR, BP, neck
circumference, chest and abdomen, collection and analysis of clinical preoperative findings, polysomnography,
pulmonary function test and a questionnaire on sleepiness.
Discussion: This paper describes a randomised controlled trial of morbidly obese patients. Polysomnography,
respiratory mechanics, chemosensitive response and quality of life will be assessed in patients undergoing or not
undergoing bariatric surgery.
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Obesity is currently one of the most serious public
health problems. The prevalence of this condition has
grown in an accentuated fashion in recent decades, even
in developing countries, leading to a global epidemic.
Over 1.6 billion adults worldwide are overweight, among
which 400 million are obese. The World Health Organi-
sation predicts that 10% of the global population will be
obese by 2015 [1]. As poverty has been undergoing a
process of eradication, obesity has become a more fre-
quent and more serious problem than malnutrition
[2,3]. In adults, overweight is characterised by a body
mass index (BMI) between 25 kg/m
2 and 29.9 kg/m
2
and obesity is defined beginning at 30 kg/m
2 [4].
When excess weight reaches very high values (BMI ≥
40 kg/m
2), obesity is considered a severe dysfunction
due to the association with diseases that are either
caused or aggravated by this condition, corresponding
to grade III obesity, which is also denominated morbid
obesity [4]. The most frequent comorbidities are sys-
temic arterial hypertension [5,6], type II diabetes melli-
tus [7], obstructive sleep apnoea [8], degenerative joint
disease [9], dyslipidemia, coronary disease [10,11],
respiratory dysfunction [12] and psychosocial problems
[13].
Obesity is the most important risk factor for obstruc-
tive sleep apnoea (OSA), especially with fat build-up in
the upper portion of the abdomen and the neck region.
At least 60 to 70% of patients with OSA are obese [14].
Moreover, the incidence among patients with Grade III
obesity is 12-fold to 30-fold greater than that in the gen-
eral population [15,16]. OSA is characterised by recur-
rent episodes of partial or complete obstruction of the
upper airway during sleep in the presence of ventilatory
effort, with a consequent drop in oxyhemoglobin satura-
tion, generating negative intrathoracic pressure and
arousals [17]. The gold standard for the diagnosis of
OSA is basal nocturnal polysomnography (PSG), which
is the simultaneous recording of physiological para-
meters during a night of sleep, involving the analysis of
sleep stages, breathing pattern, cardiovascular function
and body movements [18,19].
The association between obesity and respiratory sleep
disorders was first described in 1918 by William Osler,
who was reminded of a Charles Dickens’ characters
nicknamed “John, the fat boy”, a plethoric snorer and
terribly sleepy [20]. The treatment of obesity in these
patients has since become a priority [21]. Common dis-
eases such as obesity and hypertension should not be
analysed without considering respiratory sleep disorder
as a possible causal factor. In recent years, the preva-
lence of such disorders has grown, affecting 40% of the
general population [22,23].
The aim of the treatment of obesity is to improve
both health and quality of life through enough of a
reduction in body weight to eliminate or improve
comorbidities and promote psychological wellbeing [24].
Medical management of obesity is routinely the first line
of treatment prescribed by physicians and lay persons
alike. Medical therapy often involves a combination of
calorie restriction, behaviour modification, increased
exercise and pharmacotherapy. Behaviour modification
in the treatment regimen may help slow the tendency
toward weight regain, but does not prevent it entirely.
Unfortunately, the medical treatment of morbid obesity
provides minimal sustained weight loss in the majority
of patients [25,26]. The fact that morbid obesity remains
largely refractory to dietary and medication therapy
makes bariatric surgery a viable option [27].
Patients with a BMI of greater than 40 Kg/m
2 or 35 to
39.9 Kg/m
2 and associated to comorbidities are candi-
dates for bariatric surgery. The most often employed
surgical methods are divided into three groups: restric-
tive, malabsorptive and mixed [28,29]. The most com-
mon techniques are Fobi-Capella surgery and
Scopinaro’s biliopancreatic diversion, which are mixed
techniques [30].
This study will sleep study, respiratory mechanics,
chemosensitive response and quality of life in morbidly
obese patients undergoing bariatric surgery.
Aims and hypotheses
The aims of this study are to assess the evolution of pul-
monary function through spirometry, ventilatory
mechanics and breathing tests as well as sleep study
parameters and quality of life in subjects suffering from
morbid obesity undergoing bariatric surgery and deter-
mine a possible correlation between weight loss and
these physiological variables. We hypothesise that the
weight loss induced by surgical intervention reduces the
impact of this disease on sleep quality, cardiovascular




The study design is a parallel-group randomised con-
trolled trial and is summarised in Figure 1, and is being
conducted according to the ethical standards established
in the 1961 Declaration of Helsinki (as revised in Hong
Kong in 1989 and in Edimburgh, Scotland in 2000).
This study is registered with the World Health Organi-
zation Universal Trial Number (UTN) U1111-1121-
8873, and Registro Brasileiro de Ensaios Clínicos (RBR-
9k9hhv), and has been approved by the Human
Research Ethics Committees of the Nove de Julho
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2009). All participants gave written, informed consent.
Subjects and recruitment procedure
Individuals with morbid obesity (BMI between 40 kg/
m
2 and 50 Kg/m
2) or BMI between 35 kg/m
2 and 39.9
kg/m
2 associated to comorbidities will be recruited
from the surgery ward of the Santa Casa de Misericór-
dia Hospital of the city of Sao Paulo (Brazil) and sent
to the Sleep Laboratory of the Universidade Nove de
Julho, Sao Paulo (Brazil). Participants will be recruited
consecutively and screened for eligibility using a
Figure 1 Flowchart representing the study design.
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described below.
Inclusion Criteria




2- Male and female patients aged 18 to 65 years;
3- Documented history of conventional weight loss
attempts having proven unsuccessful over time;
4- Agreement to participate in the study through a
signed term of informed consent.
Exclusion Criteria
1- Any medical condition rendering surgery too
risky;
2- BMI above 55 kg/m
2;
3- Clinically significant or unstable mental health
concerns;
4- Unrealistic postoperative target weight and/or
unrealistic expectations of surgical treatment;
5- Pregnancy, lactation or planned pregnancy within
two years of potential surgical treatment;
6- Lack of safe access to abdominal cavity or gastro-
intestinal tract;
7- Smoking (at least 8 weeks prior to surgery), abu-
sive alcohol use or drug use.
Randomisation
Following the initial evaluation and fulfilment of the
eligibility criteria, the subjects will be randomly dis-
tributed into an intervention group [bariatric surgery
group (BSG)] and control group (CG). Randomisation
numbers will be generated using a randomisation
table at a central office. A series of numbered, sealed,
opaque envelopes will be used to ensure confidential-
ity. Each envelope will contain a card stipulating to
which group the subject will be allocated. This rando-
misation criterion will be used due to the enormous
number of candidates for bariatric surgery and the
limited capacity of the surgical ward to meet this
demand. All subjects submitted to this randomisation
protocol will meet the eligibility criteria and will be
clinically stable.
Sample size
A previous study published by Lettieri et al. (2008) [31]
identified a mean reduction in the Apnoea-Hypnoea
Index of 23.4 events/hour in morbidly obese patients
submitted to bariatric surgery (expected size effect).
Using a standard deviation of 22.8 events/hour from the
same study and considering a = 0.05 and power = 80%,
the sample was estimated as 17 patients.
Study interventions
Evaluation
All evaluations will occur prior to the surgical interven-
tion. The patients submitted to bariatric surgery will be
evaluated again 30, 90 and 360 days following the proce-
dure. All subjects in both groups will be submitted to
the following evaluation protocol.
Clinical evaluation
General physical measurements and PSG will be per-
formed a week prior to preparation for the surgery by a
well-trained physician and physical therapist following
recommended procedures and using precise instruments
and will include body weight (kg), height (m), calcula-
tion of body mass index (BMI) using the formula
weight/height
2 [32], circumferences (cm) of the neck,
waist, and hip [33], heart and respiratory rates, blood
pressure values, Mallampati index [34], tonsil index [35],
the administration of specific questionnaires for sleep
apnoea and excessive daytime sleepiness [36] and a
quality of life questionnaire [37].
Educational and psychological program
During the initial evaluations, all patients will take part
in an educational program in the auditorium of Santa
Casa de Misericordia Hospital, where they will receive
information on the development and progression of
obesity, treatment (pharmacological and non-pharmaco-
logical) and the importance of regular physical activity
practice. All patients will receive a chart containing the
educational program [38].
Waist and neck circumference
The measurements of waist and neck circumference will
be performed with a metric tape (7 mm in width). The
sites of the measurements will be standardized. Waist
circumference will be measured at the mid point
between the lower edge of the last rib and the iliac
crest. Neck circumference will be measured horizontally
over the cricoid cartilage [39].
Thorax and abdomen cirtometry
Cervical thoracoabdominal cirtometry will be carried out
to assess thorax and abdomen mobility and define the
diaphragm index. The measurement will be performed
b yf i x i n gt h ez e r op o i n to nt h em e t r i ct a p et ot h ea n t e -
rior region of the thorax at the level that is being mea-
sured (axillary, xiphoid or abdominal), with the tape
enveloping the entire thorax or abdomen with maximal
possible pressure and the other extremity of the tape
placed over this same fixed point. The aim of the maxi-
mal possible pressure of the tape on the body is to
avoid the interference of soft structures in the measure-
ments. Mobility and range of motion are provided by
maximal inspiration and expiration [40].
Pulmonary function tests
Spirometry The lung function tests will be carried out
with the patient seated in a comfortable position using
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Louisville, CO, USA) and following guidelines for the
execution of pulmonary function tests of the Brazilian
Society of Pneumology [41] and the European Respira-
tory Society [42]. The subjects will perform the test
seated as comfortably as possible, with the body erect
and the upper limbs unsupported. All exams will be car-
ried out by a technician trained in obtaining the neces-
sary cooperation from the subjects and appropriately
operating the equipment in order to ensure accurate,
reproducible results. The equipment will be calibrated
prior to each exam with a 3-L syringe [41].
Analysis of respiratory mechanics Maximal inspira-
tory pressure (MIP) and maximal expiratory pressure
(MEP) physiologically constitute the most adequate test
for the determination of respiratory muscle strength.
MIP is an indicator of ventilatory capacity and the
development of respiratory failure and is indicated for
the assessment of the degree of abnormality and moni-
toring of the weakening of inspiratory muscles indivi-
dually in the progress of patients [43]. The tests will
occur on the same day in which the patients undergo
spirometry. The tests will be performed in a quiet set-
ting. The patients will be seated comfortably, with the
trunk at a 90-degree angle in relation to the thighs and
breathing calmly and at rest [41].
Rebreathing test In this study protocol, we will employ
the re-inhalation method described by Read [44]. This is
a simple technique that has been validated in the litera-
ture and allows the determination of the ventilatory
response to CO2 stimulus. The patients will breathe
through a mouthpiece and, after achieving a steady
state, basal ventilation will be recorded for three min-
utes. The patients will then breathe connected to a 15-L
latex balloon filled with a 7% CO2 and 93% O2 mixture
for five minutes or until an end-tidal CO2 pressure
(PetCO2) of 70 mm Hg is reached or until exhaustion.
Data will be collected using a spirometer. The slope of
ventilatory response to carbon dioxide will be obtained
from a linear regression between ventilation and
PetCO2. The data will be adjusted by a 0.9 correction
factor to correct flow readings for hyperoxic gas mix-
ture. The rebreathing tests will be carried out at Santa
Casa de Misericordia Hospital (Sao Paulo, Brazil). All
manoeuvres will be carried out by physicians.
Epworth Sleepiness Scale The Epworth Sleep Scale is a
simple, self-administered questionnaire with items
addressing situations of daily activities and the occur-
rence of daytime sleepiness in adults. The subjects will
be instructed to classify their likelihood of feeling the
desire to nap or sleep in eight situations on a scale of 0
to 3 (0 = no chance of napping; 1 = small chancing of
napping; 2 = moderate chance of napping; and 3 =
strong chance of napping) [45,46].
Berlin Questionnaire The Berlin Questionnaire is used
to identify patients at high risk for sleep disordered
breathing in a variety of populations. This clinical his-
tory questionnaire has recognized efficacy in distinguish-
ing individuals at greater risk for OSA, with ten items
organized into three categories: snoring and apnoea (5
items), daytime sleepiness (4 items), systemic arterial
hypertension and obesity (1 item). Any marked response
is considered positive. The score is divided into cate-
gories. Category 1 is considered positive when there are
two or more positive responses to Items 1 to 5. Cate-
gory 2 is considered positive when there are two or
more positive responses to Items 6 to 8. Category 3 is
considered positive when the response to Item 9 is “yes”
or at BMI equal to or greater than 30 kg/m
2.T w oo r
more positive categories indicate high risk [47].
Polysomnography A complete full-night PSG will be
performed using a digital system (Embla, A10 version
3.1.2 Flaga, Hs. Medical Devices, Iceland) at the Sleep
Laboratory of Universidade Nove de Julho. All recording
sensors will be attached to the patient in a non-invasive
manner using tape or elastic bands. The following phy-
siological variables will be monitored simultaneously
and continuously: four channels for the electroencepha-
logram (EEG) (C3-A2, C4-A1, O1-A2, O2-A1), two
channels for the electrooculogram (EOG) (EOG-Left-
A2, EOG-Right-A1), four channels for the surface elec-
tromyogram (muscles of the submentonian region, ante-
rior tibialis muscle, masseter region and seventh
intercostal space), one channel for an electrocardiogram
(derivation V1 modified), airflow detection via two chan-
nels through a thermocouple (one channel) and nasal
pressure (one channel), respiratory effort of the thorax
(one channel) and the abdomen (one channel) via x-
trace belts, snoring (one channel) and body position
(one channel) via EMBLA sensors, and arterial oxygen
saturation (SaO2) and pulse rate via an EMBLA oxi-
meter. All PSGs will be performed and sleep stages
visually scored according to standardized criteria for
investigating sleep [48,49]. EEG arousals, sleep-related
respiratory events and leg movements will be scored in
accordance with the criteria established by the American
Academy of Sleep Medicine Manual for Scoring Sleep
and Associated Events [50].
The patients will be instructed to remain as relaxed as
possible and sleep naturally, as if at home. All signals
will be recorded continuously. Throughout the night,
the subjects will be monitored by a technician experi-
enced in polysomnography [49].
Bariatric surgery
Bariatric surgery will be performed on the subjects
selected for the procedure at the Santa Casa de Miseri-
córdia Hospital by experienced specialists. The surgical
techniques employed for the treatment of obesity are
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aim of restrictive techniques (vertical gastroplasty with
banding or Mason’s surgery, adjustable gastric band) is
to reduce gastric capacity in order to promote early sati-
ety, thereby reducing the volume of food ingested. The
aim of malabsorptive techniques (jejunoileal bypass or
Payne’s operation) is to reduce the absorption of foods
through the exclusion of a segment of small intestine.
Mixed techniques [Fobi-Capella surgery, Scopinaro’s
biliopancreatic diversion, and a Scopinaro technique
modified by Marceau and Biron (duodenal-switch)]
combine mechanical restriction to the food bolus and
intestinal malabsorption [51,52].
Bariatric Analysis and Reporting Outcome System (Baros)
The Bariatric Analysis and Reporting Outcome System
(BAROS) introduced by Oria and Moorhead in 1997 [53]
provides a standard for comparisons of surgical treatment
in patients with morbid obesity. This system adds or sub-
tracts points in the evaluation of three main areas (percen-
tage of excess weight loss, changes in medical conditions
and assessment of quality-of-life), considering four out-
come groups (failure, fair, good and excellent). Points are
deducted for complications and reoperative surgery. The
comorbidities taken into account by BAROS are hyperten-
sion, cardiovascular disease, dyslipidemia, type 2 diabetes,
sleep apnoea syndrome, osteoarthritis and infertility. Idio-
pathic intracranial hypertension, lower extremity venous
stasis disease, gastroesophageal reflux and urinary stress
incontinence become comorbidities when these conditions
impair or diminish quality of life or require long-tem
treatment [54].
Quality control
In order to ensure data quality, the physiotherapists and
physicians in charge of the data acquisition in this study
will receive specific training. Periodic external monitor-
ing will be performed to verify the adequate application
of the methodology in collecting information and per-
forming the different examinations. The results of the
preoperative and postoperative exams will be analysed
by blinded evaluators.
Statistical analysis
Data will be presented as means ± standard deviation,
when applicable. For comparison of continuous variables
before and after bariatric surgery, it will be used the
paired Student t-test or Wilcoxon tests as appropriate.
Comparisons between groups will be performed using
Student t test or Mann-Whitney U according to the
distribution.
All tests will be 2 tailed, and p values of less than 0.05
will be assumed to represent statistical significance.
Multivariate linear regression will be used to identify
independent predictors of the AHI following surgical
weight loss. All analyses will be done using SPSS ver.
16.0 [55].
Discussion
Obesity is a chronic and often a life-long disease. It is a
major cause of preventable death and is associated with
a range of negative physiological and psychological con-
sequences [56]. The aim of this study is to analyse clini-
cal parameters referring to anthropometric data,
pulmonary function tests, respiratory mechanics, sleep
study, sleepiness scale and chemosensitive response to
CO2 in patients with morbid obesity submitted to baria-
tric surgery. If successful, this project will help reduce
the negative health, economic and social consequences
of obesity.
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